CAPER as a therapeutic target for triple negative breast cancer

Breast cancers (BCas) that lack expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are referred to as triple negative breast cancers (TNBCs) and have the poorest clinical outcome. Once these aggressive tumors progress to distant...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Mallory C., Pontiggia, Laura, Russell, Ashley Y., Schwarting, Roland, Camacho, Jeanette, Jasmin, Jean-Francois, Mercier, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084388/
https://www.ncbi.nlm.nih.gov/pubmed/30100993
http://dx.doi.org/10.18632/oncotarget.25719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084388/
https://www.ncbi.nlm.nih.gov/pubmed/30100993
http://dx.doi.org/10.18632/oncotarget.25719

Ejemplares similares